Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00359944 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease
A Phase 2 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 2
- Development phase
- 171
- Enrollment target
NCT00359944 is a Phase 2 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 171 participants.
The verdict
NCT00359944, a Phase 2 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 171 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate efficacy and safety of different doses of AC-3933 in patients with mild to moderate Alzheimer's Disease.
Interventions
- OTHER Sugar Pill
- DRUG AC-3933
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00359944
The ClinicalTrials.gov registry entry for NCT00359944 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sumitomo Pharma America, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sugar Pill is the first listed.
NCT00359944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00359944 about?
NCT00359944 is a clinical study titled "Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease". The purpose of this study is to investigate efficacy and safety of different doses of AC-3933 in patients with mild to moderate Alzheimer's Disease.
What is the current status of trial NCT00359944?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 171 participants. The study started on 2006-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00359944?
The interventions under investigation include: Sugar Pill (OTHER), AC-3933 (DRUG).
Who is sponsoring clinical trial NCT00359944?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.